Lymphoma: Radioimmunotherapy Using Iodine-131 Labeled Murine Anti-CD20 Antibodies (131I-Tositumomab and Tositumomab, “Bexxar”) | Radiology Key
Potential anti-CD20 mAb effector mechanisms. (A) Fc-Fc ␥ R–dependent... | Download Scientific Diagram
Anti-CD20 monoclonal antibodies in Systemic Lupus Erythematosus - ScienceDirect
CD20 Monoclonal Antibodies Drugs: There is an Explosion of New mAbs Against CD20! - Cusabio
Overcoming rituximab drug-resistance by the genetically engineered anti-CD20-hIFN-α fusion protein: Direct cytotoxicity and synergy with chemotherapy
Anti-CD20 therapies for multiple sclerosis: current status and future perspectives | SpringerLink
The future of anti-CD 20 monoclonal antibodies : are we making progress ? | Semantic Scholar
Rituximab (monoclonal anti-CD20 antibody): mechanisms of action and resistance | Oncogene
Treatment of multiple sclerosis with anti-CD20 antibodies. | Semantic Scholar
The effects of type I and type II anti-CD20 mAb binding to CD20 on... | Download Scientific Diagram
Anti-CD20 Antibody Therapy for B-Cell Lymphomas | NEJM
Comparison of commercially available anti-CD20 antibodies | Download Table
Establishment of C20Mab‑11, a novel anti‑CD20 monoclonal antibody, for the detection of B cells
Development of Anti-CD20 Antigen-Targeting Therapies for B-cell Lymphoproliferative Malignancies - The State of the Art | Bentham Science
Ublituximab: A Novel Anti-CD20 Therapy for Multiple Sclerosis - touchNEUROLOGY
Anti‐CD20 Antibody Rituximab in the Treatment of Rheumatoid Arthritis - Korhonen - 2010 - Basic & Clinical Pharmacology & Toxicology - Wiley Online Library
CD20 Monoclonal Antibodies Drugs: There is an Explosion of New mAbs Against CD20! - Cusabio
Anti-CD20 monoclonal antibodies: historical and future perspectives | Haematologica
Noninvasive Evaluation of CD20 Expression Using 64Cu-Labeled F(ab′)2 Fragments of Obinutuzumab in Lymphoma | Journal of Nuclear Medicine
Unraveling the T–B tangle in anti-CD20 multiple sclerosis therapy | PNAS
Learning multiple sclerosis immunopathogenesis from anti-CD20 therapy | PNAS
Rituximab, an Anti‐CD20 Monoclonal Antibody: History and Mechanism of Action - Pescovitz - 2006 - American Journal of Transplantation - Wiley Online Library
Mechanisms of action of anti-CD20 monoclonal antibodies. Abbreviation:... | Download Scientific Diagram
Anti-CD20 monoclonal antibodies in chronic lymphocytic leukemia: from uncertainties to promises | Immunotherapy
anti-CD20 (Rituximab) - ACE Biolabs Antibody │ Chemical │ Enzyme
Anti-CD20 Directed Therapy of B Cell Lymphomas: Are New Agents Really Better? | SpringerLink
